Philip Morris quarter earnings

Source: Dukascopy Bank SA
Philip Morris International reported strong Q1 2025 results, driven by growth in smoke-free products. Smoke-free products like IQOS and ZYN made up 42% of total revenue, with net revenue up 20% and gross profit up 33%. These products are now available in 95 markets. IQOS continued to gain market share in Japan and Europe, while ZYN nicotine pouches grew 53% in the U.S. Vaping product VEEV more than doubled its shipment volumes, especially in Europe. Cigarette sales were flat overall but grew 3.8% organically, with brands like Marlboro gaining market share.



Total revenue for the quarter was $9.3 billion, up 10% organically. Gross profit was $6.3 billion, up 16% organically. Adjusted earnings per share (EPS) was $1.69, or $1.76 excluding currency effects, up 17% year-over-year. PMI expects full-year adjusted EPS of $7.36 to $7.49, representing 12–14% growth compared to 2024, or 10.5–12.5% growth excluding currency. The company remains focused on expanding its smoke-free portfolio and expects continued strong performance for the rest of the year.
Back to articles

Actual Topics

Fri, 25 Apr 2025 12:00:03 GMT

Boeing quarter earnings

Boeing's first-quarter 2025 financial results highlighted revenue growth to $19.5 billion, an 18% increase from last year, despite a GAAP loss per share of $0.16 and a core loss per share of $0.49. Commercial Airplanes saw a revenue rise to $8.1 billion, up 75%, driven by 130 airplane deliveries, with increased production in the 737 program and stable production in

Wed, 16 Apr 2025 11:44:05 GMT

Johnson & Johnson quarter earnings

Johnson & Johnson delivered strong first-quarter results, highlighting the strength of its diversified business model. The company reported total sales of $21.9 billion, a 2.4% increase compared to the same period last year. Net earnings surged to $11 billion, up 238%, driven in part by a one-time gain. Adjusted earnings per share rose 2.2% to $2.77, while free cash flow reached

Subscribe to "Fundamental Analysis" feed

Subscribe
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.